This protocol targets vestibular migraine occurring in patients with menstrually associated migraine — attacks that are predictably tied to the menstrual cycle. Because onset is anticipated, a short-term preventive strategy initiated before the expected attack window is central to management.
The evidence-based approach centres on short-term prevention using a triptan or an NSAID, started ahead of the anticipated migraine onset. The specific agent of choice, supporting evidence, and the full administration details are set out in the complete structured protocol.
Agent selection, timing, and the complete regimen are in the full protocol below.